Navigation Links
Oncothyreon's PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover
Date:11/16/2009

. Based on these data, we are excited by our plan to advance this compound into Phase 2 development next year."

"Oncothyreon's PX-866 was selected following a screening using a strict set of judging criteria for the Top 10 award and it represents what our committee considered one of the most attractive oncology opportunities the industry has to offer," said Roger Longman, Managing Director of Windhover Information. "PX-866 has met rigorous criteria including: unmet medical need, market potential, diversity of indications, strong science, multi-level partnering opportunities (biotech and pharma), potential for new opportunities beyond initial indications, and corporate stability."

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

Forward-Looking Statements

In order to provide Oncothyreon's investors with an understanding of our current results and future prospects, this release may contain statements that are forward-looking. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends," "potential," "possible" and similar expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, clinical and pre-clinical development activities, including our decision to move PX-866 into Phase 2 clinical development in the first half of 2010 or the possibility that we may obtain a partner for PX-866.

Forwar
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Data for Oncothyreons PX-12 and PX-866 presented at AACR Annual Meeting
2. Oncothyreon files investigational new drug application for PX-866 oncology compound
3. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
4. Oncothyreons PX-866 is effective in preclinical model of pulmonary fibrosis
5. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
6. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
7. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
8. ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
9. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
10. CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
11. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... of how facets form and develop on platinum ... effective nanocrystal design and reveal that a nearly ... down at the nanoscale. , Researchers with the ... Laboratory (Berkeley Lab) used highly sophisticated transmission electron ... capture the physical mechanisms that control the ...
(Date:8/22/2014)... 2014 Ophthalmic drug delivery technologies ... challenging endeavors as the anatomy, physiology and biochemistry ... the foreign substances. Ocular drug delivery technologies provide ... and minimal use of needles; also it enables ... provides specific targeting within the ocular globe. On ...
(Date:8/22/2014)... 22, 2014 Research and Markets ... China Gel Permeation Chromatography (GPC) Industry Report 2014" ... and China Gel Permeation Chromatography (GPC) Industry Report is ... of the global gel permeation chromatography industry with a ... a basic overview of the industry including definitions, classifications, ...
(Date:8/22/2014)... The AMA is pleased to share with the ... Alaska Governor Sean Parnell has signed House Bill 255 ... of Unmanned Aircraft Systems and the continuation of the ... it is, “An Act relating to unmanned aircraft systems; ... system.” It defines State of Alaska laws regarding data ...
Breaking Biology Technology:Shaping the future of nanocrystals 2Shaping the future of nanocrystals 3Shaping the future of nanocrystals 4Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Global and China Gel Permeation Chromatography (GPC) Industry Report 2014 2State of Alaska Signs Unmanned Aircraft Systems Bill 2
... Insurance are recruiting information technology workers to ... Valley earlier next year. , ,The Stevens Point-based insurer plans ... a rich pool of talent in the area and improvements ... to Appleton and other Fox Valley communities. ...
... radio frequency identification can improve the speed and ... at the University of Wisconsin-Madison is partnering ... is being called an "end-to-end" research project. , ,The project, ... transfusion, involves the Blood Center of Wisconsin , ...
... - The first segment of a national and international ... the announcement that CellCura, Inc. , a Norwegian biotechnology ... in Madison's University Research Park . , ,CellCura, the ... during the past two years, chose Madison following an international ...
Cached Biology Technology:RFID pilot project aims to improve blood banks 2RFID pilot project aims to improve blood banks 3CellCura could start an invasion of stem cell firms 2CellCura could start an invasion of stem cell firms 3
(Date:8/21/2014)... Oct. 18-22, 2014 , WHERE: , San ... Diego, CA 92101 , WHAT: , Invited ... the latest research in human genetics. Examples of ... abstracts on rare genetic variants in health and ... for sun sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) ...
(Date:8/21/2014)... replicated one of the crucial steps in photosynthesis, opening ... could manufacture hydrogen as a fuel. , "Water is ... prospect to use them to create hydrogen, and do ... the ARC Centre of Excellence for Translational Photosynthesis in ... potential as a zero-carbon replacement for petroleum products, and ...
(Date:8/20/2014)... ITHACA, N.Y. In a study of 158 pregnant ... the craving and intentional consumption of ice, cornstarch, ... items, reports a new Cornell study. , Moreover, such ... teens who did not eat nonfood substances. , Pregnant ... low hemoglobin, which can lead to iron deficiency and ...
Breaking Biology News(10 mins):American Society of Human Genetics 2014 Annual Meeting 2Water and sunlight the formula for sustainable fuel 2Pica in pregnant teens linked to low iron 2
... research at UC Santa Barbara is contributing to the basic ... of the campus,s expanding vision research. The new studies ... of the National Academy of Sciences (PNAS), and ... document how they used mice as a research model organism ...
... King Juan Carlos University (URJC) have carried out a ... whether spiders were more tolerant of human impact than ... consequences of changes to their landscape just like any ... spider species is negatively affected by the impact of ...
... a key role in a major public/private partnership to evaluate ... sustainable UK energy system for 2050. Domestic biomass (a ... as plants, rubbish and wood), sustainably grown in the UK, ... UK,s energy needs by 2050 and significantly contribute to the ...
Cached Biology News:UCSB scientists make strides in vision research 2Spiders suffer from human impact 2Southampton scientists to help create a sustainable energy system for the UK 2Southampton scientists to help create a sustainable energy system for the UK 3
... is a recombinant protein that has been shown ... the preparation of cDNA by reverse transcription, in ... synthesis. RNA Safe Inhibitor tightly binds RNases in ... of eukaryotic RNases such as RNase A, RNase ...
... and Recombinant RNasin Ribonuclease Inhibitors have broad ... of eukaryotic RNases of the neutral type ... effect by noncovalently binding to RNases in ... the binding of RNasin Ribonuclease Inhibitor to ...
...
Canine Aortic Smooth Muscle Cells (CnAOSMC) (>500,000 cells)...
Biology Products: